Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splice modulating payloads, today announced that the Company will ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splice modulating ...

Company will trade on Nasdaq under trading symbol 'DMRA' effective March 10, 2026 ---- On track to submit IND or CTA for DMR-001 in ...

Summary The Doomsday Clock seeks to capture the severity of the existential threats facing humankind, as understood by the Bulletin of the Atomic Scientists. While initially focused on nuclear ...

DeepSeeks AI Launches Target U.S. Tech Hegemony Correspondent Report Chinas Three-Tier Strategy Positions AI as Foundation for Emerging, Future Industries ...

Throughout history, humanity has displayed a remarkable talent for getting things spectacularly wrong when it comes to innovation. We've dismissed ...

In pluralistic societies, innovations offering new ways to promote independence or individuality are generally rapidly embraced, whereas those that appear to centralize power and authority are either ...

Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression 14-Month Follow-up Data Show Hypoimmune (HIP)-Mod ...

This report surveys opportunities for future Army applications in biotechnology, including sensors, electronics and computers, materials, logistics, and medical therapeutics, by matching commercial ...

The Toxic Substances Control Act (TSCA) provides critical protections for commercially sensitive information related to a company’s ...